BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taghiabadi M, Hosseini SY, Gorzin AA, Taghavi SA, Monavari SHR, Sarvari J. Comparison of pre-S1/S2 variations of hepatitis B virus between asymptomatic carriers and cirrhotic/hepatocellular carcinoma-affected individuals. Clin Exp Hepatol 2019;5:161-8. [PMID: 31501793 DOI: 10.5114/ceh.2019.84781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Sanaei N, Hashemi SMA, Dehno SZS, Asl MM, Moini M, Malek-Hosseini SA, Hosseini SY, Sarvari J. Precore/core mutations of hepatitis B virus genotype D arising in different states of infection. Clin Exp Hepatol 2022;8:21-8. [PMID: 35415256 DOI: 10.5114/ceh.2022.114253] [Reference Citation Analysis]
2 Marlet J, Lier C, Roch E, Moreau A, Combe B, Handala L, Lefeuvre S, Maugey M, Elkrief L, d'Alteroche L, Potier P, Brand D, Gaudy-Graffin C. Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure. Antiviral Res 2021;192:105106. [PMID: 34214504 DOI: 10.1016/j.antiviral.2021.105106] [Reference Citation Analysis]
3 Wu J, Yu Y, Dai Y, Zhang Y, Cheng J, Cui D. Research Progress on the Mechanism of Persistent Low-Level HBsAg Expression in the Serum of Patients with Chronic HBV Infection. Journal of Immunology Research 2022;2022:1-11. [DOI: 10.1155/2022/1372705] [Reference Citation Analysis]
4 Maepa MB, Bloom K, Ely A, Arbuthnot P. Hepatitis B virus: promising drug targets and therapeutic implications. Expert Opin Ther Targets 2021;25:451-66. [PMID: 33843412 DOI: 10.1080/14728222.2021.1915990] [Reference Citation Analysis]